Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosimilar medicines worldwide.
ALVO | LU
Overview
Corporate Details
- ISIN(s):
- LU2458332611
- LEI:
- 222100DCZBOWV5DZ8372
- Country:
- Luxembourg
- Address:
- 9, RUE DE BITBOURG, L-1273 LUXEMBOURG
- Website:
- https://www.alvotech.com/
- Sector:
- Manufacturing
Description
Alvotech is a biotechnology company that specializes in the development and manufacturing of biosimilar medicines for patients worldwide. The company's mission is to improve lives by expanding access to high-quality, affordable biologic medicines. Alvotech operates a fully integrated, end-to-end platform that encompasses the entire process from cell line development through to fill and finish manufacturing. This vertically integrated approach provides control over scale, speed, and quality. For commercialization and registration in global markets, Alvotech leverages strategic partnerships, allowing it to maintain a singular focus on its core development and manufacturing expertise. The company's product pipeline targets various therapeutic areas, including autoimmune and eye disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-22 21:26 |
Fjárhagsdagatal Alvotech fyrir árið 2026
|
Icelandic | 1.7 KB | ||
| 2025-12-22 21:26 |
Alvotech's Financial Calendar for 2026
|
English | 1.6 KB | ||
| 2025-12-22 08:00 |
Alvotech og Advanz Pharma hefja sölu í Evrópu á fyrstu hliðstæðunni við Simponi
|
Icelandic | 4.9 KB | ||
| 2025-12-22 08:00 |
Alvotech announces European launch of first-in-market biosimilar to Simponi® (g…
|
English | 8.2 KB | ||
| 2025-12-19 09:30 |
Alvotech og Teva ná samningi um að sala AVT06 hliðstæðunnar við Eylea má hefjas…
|
Icelandic | 6.2 KB | ||
| 2025-12-19 09:30 |
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar …
|
English | 12.0 KB | ||
| 2025-12-17 08:30 |
Mikil umframeftirspurn alþjóðlegra fjárfesta í útboði Alvotech á breytanlegra s…
|
Icelandic | 8.4 KB | ||
| 2025-12-17 08:30 |
Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds…
|
English | 23.1 KB | ||
| 2025-12-16 17:48 |
Alvotech býður út breytanleg skuldabréf að fjárhæð 100 milljónir bandaríkjadala…
|
Icelandic | 13.1 KB | ||
| 2025-12-16 17:48 |
Alvotech Launches $100 Million Senior Unsecured Convertible Bond Offering to Co…
|
English | 28.6 KB | ||
| 2025-11-24 11:30 |
Markaðsleyfi veitt á Evrópska efnahagssvæðinu fyrir AVT03, hliðstæðu Alvotech v…
|
Icelandic | 8.4 KB | ||
| 2025-11-24 11:30 |
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denos…
|
English | 13.3 KB | ||
| 2025-11-20 10:00 |
Alvotech og Advanz Pharma fá markaðsleyfi á Evrópska efnahagssvæðinu fyrir Gobi…
|
Icelandic | 7.4 KB | ||
| 2025-11-20 10:00 |
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Econo…
|
English | 13.7 KB | ||
| 2025-11-12 22:40 |
Alvotech kynnir uppgjör fyrstu níu mánaða ársins 2025 og helstu áfanga í rekstr…
|
Icelandic | 24.6 KB |
Automate Your Workflow. Get a real-time feed of all Alvotech Holdings S.A filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alvotech Holdings S.A
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alvotech Holdings S.A via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
